Ruxandra Draghia-Akli
Head of R&D
Other
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Novavax Inc (NVAX) | M.D., Ph.D. Former EVP, Head of Research & Development | $600,000 | $2,303,380 |
Earnings-call appearances
-
Novavax Inc Q4 FY2025 Earnings Call2026-02-26
Novavax Inc (NVAX)
-
Novavax Inc Q3 FY2025 Earnings Call2025-11-06
Novavax Inc (NVAX)
-
Novavax Inc Q2 FY2025 Earnings Call2025-08-06
Novavax Inc (NVAX)
-
Novavax Inc Q1 FY2025 Earnings Call2025-05-08
Novavax Inc (NVAX)
-
Novavax Inc Q4 FY2024 Earnings Call2025-02-27
Novavax Inc (NVAX)